Stem Cell Treatments for Autism – “Oh my god the speech!!! He’s TALKING I mean real speech and conversation!!! Today was crazy!!!”

This new facebook update on Anthony Guerriero says it all:

Autism Stem Cell Patient Anthony Guerriero

“Oh my god the speech!!! He’s TALKING I mean real speech and conversation!!! Today was crazy!!! Anthony was TELLING us all about his birthday, what he wants to do, counting down the days, what presents he wants, what he wants from Santa vs his birthday, all about Halloween and what each of us is going to be (Mommy is Blue toad, Bella is princess peach, daddy is luigi and Anthony now wants to be Mario), telling us what all the costumes are and what he’s wearing, what he did in school today, what he’s doing tomorrow for his last day, what he wants to play with and with who, what he wants for dinner (tried a new food too), how many days til we go to Maine, what we’re going to do there!!!!!! And on and on. Crazy crazy crazy!!! All spontaneous!!! All TALKING !!! It’s happening big time!!!!! WOW!!!”

Anthony Guerriero FB Comments 8-4-15

Anthony Guerriero FB Comments 8-4-15

Visit Anthony’s Facebook Page Here

Read original news story about Anthony here: Autistic Woodbridge boy making strides after stem cell treatment in Panama

Bixby family raises money for son with cerebral palsy to receive second round of stem cell therapy

Stem Cell Recipient Easton WallaceBIXBY, Okla. – A Bixby family has new hope for their three- year-old son with cerebral palsy. Easton Wallace went to Panama last year to receive stem cell therapy. Unfortunately, the therapy is not FDA-approved in the United States.

The Wallace family held everything from spaghetti dinners to golf tournaments to raise the money for their son’s first treatment. His mother believes it was worth it. She says Easton is learning to talk and gain upper body strength. That is why she is hoping to raise enough money for a second treatment.

“He’s the happiest little boy ever. He can make anyone smile. He’s always smiling,” says Cassie Wallace.

Easton Wallace is a typical toddler. He loves playing outdoors and spending time with family. But unlike most other kids, Easton is living with spastic quadriplegic cerebral palsy, which affects every aspect of his life.

“He can’t sit unattended. He can stand up. He can’t crawl or walk or anything like that,” says Cassie. “He has trouble with his fine motor skills, eating.”

It’s hard for Cassie to watch her son struggle. But she says Easton’s infectious smile and loving personality give her strength.

She told 2 Works for You, “I try to be positive. We are just trying to everything we can for him to give him the best life possible. He has such a positive attitude. He’s so happy and determined. So I think that makes it easier.”

Cassie says a big part of giving Easton the best life possible, is taking him to Panama to receive Stem Cell therapy. She says the $20,000 treatment is not covered by insurance.

Easton’s first treatment was last December. Cassie say it’s working

“He’s repeating everything. He’s putting more words together. It’s really been helping.”

Cassie showed 2 Works for You video of Easton pushing himself in a device called a “pacer” for the very first time. She says this was a big day for their family because they never know for sure what milestones their child will get to experience. That’s why she and her family are trying to raise enough money to cover the expenses for another trip to Panama in December of this year.

The family is organizing another golf tournament in Sapulpa on August 29 at Clary Fields Golf Club. The event is called the “Easton Open.” There is still time to sign up by calling 918-248-4080.

You can also donate directly to the cause by logging on to Easton’s give forward page here.

Original Story and Video on KJRH Tulsa Website

Colton’s walking after stem cell therapy for cerebral palsy in Panama

Colton is planning on coming to Panama for follow-up treatment later this year. Here is a video of him walking from June 2015.

And here was Colton in 2014 about one year prior to the video above. This video was taken a year after his first treatments in 2013.

To keep up with Colton’s progress on Facebook, please visit:

Update on Glenburn Boy Who Underwent Stem Cell Therapy for Autism in Panama


JUN 8, 20155:54 PM EDT

In 2009, an 8-year old Glenburn boy became the first child in Maine, and one of less than a hundred nationwide, to undergo stem cell therapy to treat his autism.

TV5 has followed the journey of Kenneth Kelley as he travelled to Panama for treatments.

It’s been about two years since his last transfusion.

Joy Hollowell checked in with the now 14-year old to see how he’s doing.
Like most brothers, 16-year old Philip and 14-year old Kenneth Kelley enjoy challenging each other on video games.

“Who is better?

Kenneth points to Philip

Typical teenager is how most would describe Kenneth…something his parents couldn’t be happier to hear.

Kenneth was diagnosed with autism when he was two.

“Many reputable people told us that he should be put in an institution,” explains Donald Kelley, Kenneth’s father. “And that just made us more determined to find a cure for him. We knew there was one out there somewhere, there had to be.”

Like many parents of autistic kids, Donald and Marty Kelley went to numerous doctors and tried countless treatments, including installing a hyperbaric chamber inside their home.

They had read about stem cell therapy. but the clinic was in Panama, and it was still a relatively new therapy.

“Seeing doctors who tell you things that finally after a while you meeting everybody and you say to yourself, well yeah, OK, yeah, I’ve heard this before,” says Donald Kelley, expressing his frustration.

The Kelleys would spend the next two years researching stem cell therapy for autism, including visiting the clinic in Costa Rica.

“This was different,” says Donald Kelley, “this was totally different.”

Kenneth underwent his first cord blood infusion at the age of 8. That very next morning, The Kelleys say they saw a difference. Within a year, Kenneth was reading and communicating. He went back five more times, until the age of 12.

“The improvements that we saw with Kenneth were amazing,” says his father. “To see your child become you know, enjoying life.”

“Before stem cells, he was just off the charts most of the time,” says Kenneth’s brother, Philip. “Screaming, kicking. I don’t remember him ever actually having a conversation with me. He’s gone from more of a person that I had to take care of to a friend.”

8-year old Caroline calls her big brother a dolphin.

“because he’s very playful and he’s very nice and intelligent,” she explains.

“It was a true blessing that he got as far as he did,” says Donald Kelley. “And that he’s where he is today.”
The Kelleys say for now, Kenneth is done with treatments. However, they would consider going back, depending upon their son’s progression.

They tell other parents of autistic kids to never give up.

The Lip TV News: Neil Riordan, PhD on Exploring New Stem Cell Treatments for MS, Arthritis, Autism and More

Stem cell treatment and research towards curing illness–from multiple sclerosis to spinal injury–is detailed by Dr. Neil Riordan. The American medical industry, obstructions to research in the states, misconceptions about stem cells, and the details about the treatment process are explained–and we look at video of patient recovery and speculate at what the future could spell for stem cell treatment and research in this Lip News interview, hosted by Elliot Hill.

Dr. Neil Riordan is the founder and Chairman of Medistem Panama, a leading stem cell laboratory and research facility – located in Panama City. His institute is at the forefront of research of the effects of adult stem cells on the course of several chronic diseases. Dr. Riordan has more than 60 scientific articles in international peer-reviewed journals. In the stem cell arena, he and his colleagues have published more than 20 articles on Multiple Sclerosis, Spinal Cord Injury, Heart Failure, Rheumatoid Arthritis.

Stem Cells Used to Successfully Treat Chronic Achilles Tendon Injury

Ocala, FL, October 06, 2014 –( Therapies, Inc. (BTI), a company that specializes in the design and development of medical devices and procedures for the regenerative medicine market, announced today that its products have been used to successfully treat a chronically injured Achilles tendon with stem cell therapy.

A case report, titled ‘Minimally Invasive Autologous Bone Marrow Concentrate Stem Cells in the Treatment of the Chronically Injured Achilles Tendon: A Case Report’, was authored by Biologic Therapies’ Chief Medical Director, Dr. R. Wade McKenna, and Chief Scientific Officer, Dr. Neil H. Riordan, founders of the Riordan-McKenna Institute in Southlake, Texas, USA (

The case involved a 56-year-old female patient complaining of a painful “knot” in her left Achilles tendon. The pain limited her ability to perform daily activities such as shopping or being up on her feet for longer than 30 minutes. She had been an active tennis player and recreational athlete, but had not been able to play tennis or jog for ten years. She reported significant pain when relaxing and great pain when walking. The patient had been to multiple physicians and had followed ten years of standard treatment with stretches and anti-inflammatories. She refused multiple offers of invasive surgery that could not promise a return to tennis.

On physical examination by Dr. R. Wade McKenna, the patient had a large, palpable knot in the Achilles tendon, very noticeable and acutely tender. An MRI scan showed severe hypertrophic changes with marked tendinopathy.

The patient received a point-of-care stem cell therapy treatment in Dr. McKenna’s office as an outpatient procedure using Biologic Therapies products. The physician drew bone marrow from her tibia (shin) bone, processed the marrow in a centrifuge to concentrate the stem cells and growth factors, then injected the stem cells and growth factors into and around her injured Achilles tendon. Prior to the injection of the concentrated stem cells and growth factors, an injection of local anesthesia was given to prevent pain. The patient reported little to no pain during or after the procedure.

After six weeks the patient reported no pain at rest and minimal pain while walking. After eight weeks, there was even less pain while walking. The knot was less than 50% of the pre-treatment size and was relatively non-tender to touch. She was back to playing tennis without significant pain or difficulty. After ten weeks the patient was doing much better. An MRI scan showed even more reduction in the size of the knot, and pain was reduced even further. After 32 weeks an MRI scan showed near complete healing of the treated Achilles tendon.

The case report has been published by the scientific journal, CELLR4, the Official Journal of The Cure Alliance. The report can be seen on the CELLR4 website at

According to Luke Whalen, Biologic Therapies’ CEO, “This is an extremely important development for Biologic Therapies. The case report shows that stem cell therapy is an effective treatment for chronic Achilles tendon injury, which has not been documented before. The report also shows that stem cell therapy for this type of injury can be administered in a physician’s office as a point-of-care outpatient procedure using Biologic Therapies products. There is no need for hospitalization and surgery as would have been the case previously.

“Another important aspect of the publication of this case report is that the scientific journal it was published by is one of the most prestigious publications in the regenerative medicine industry. The members of the CELLR4 Journal Editorial Board that reviewed and approved the report are literally the ‘who’s who’ of regenerative medicine professionals from around the world. We are honored that they chose to publish the report. This helps to reinforce Biologic Therapies’ position as a global leader in regenerative medicine,” said Whalen.

The CELLR4 Editorial Board is led by Editor in Chief, Camillo Ricordi
from the Cell Transplant Center and Diabetes Research Institute at the University of Miami, Miami, Florida, USA. Other editorial staff of note include the Associate Editor for Asia, Jianming Tan
of Fuzhou General Hospital, Xiamen University, China; Assistant Editor, Antonello Pileggi of the Cell Transplant Center and Diabetes Research Institute at the University of Miami, Miami, Florida, USA; and Assistant Board member Arnold I. Caplan
from Case Western Reserve University, Cleveland, Ohio, USA.

In the late 1980’s, Dr. Arnold Caplan and colleagues developed and patented the technology to isolate adult human mesenchymal stem cells (MSCs) from bone marrow and to preserve their multi-potency (Caplan et al., 2001; Koc et al., 1999; Lennon et al., 2006). Adult human MSCs are capable of differentiating into a number of tissue types including bone, cartilage, muscle, marrow, tendon, ligament, adipocytes, and connective tissue.

Over 100 scientists, physicians, researchers and educators from around the world make up the CELLR4 Editorial Board. A complete listing of the Board members can be found at

About CELLR4
CELLR4 ( is a scientific journal with particular focus on cellular repair, replacement, regeneration, reprogramming and differentiation. Its scope ranges from fundamental new discoveries in basic science to translational, clinical trials and delivery of novel therapeutic options. As the official journal of the international non-profit organization The Cure Alliance, CELLR4 serves as a platform for discussion of challenges and opportunities on the path to the development of new treatments, independently from the disease target. CELLR4 publishes commentaries and opinion papers on regulatory, legal, and ethical issues, as well as information on global collaborative platforms and funding opportunities of interest to the field.

CELLR4 also serves as the official journal of the Fondazione Cure Alliance Onlus, another non-profit international organization that include physicians, scientists, patients, patient advocates, business and philanthropy leaders, with the mission to promote collaborative efforts worldwide, while addressing and working to resolve impediments and challenges on the path to develop cures for diseases now afflicting humankind. In this direction, the publication serves as a shared communication platform to discuss challenges and opportunities on the path to develop new treatments.

About Biologic Therapies
Based in Ocala, Florida, Biologic Therapies, Inc. (, is a company with a principal strategy of seeking out and developing innovative, proprietary and patented technologies to meet the needs of the rapidly emerging science of regenerative medicine, including stem cell therapy. Biologic Therapies provides groundbreaking medical technologies that significantly enhance the body’s natural healing ability, thereby providing patients with improved outcomes and quicker restoration of function. The Company’s products provide access to the biologics / regenerative medicine sector of the healthcare market.

Another competitive ballroom dancer back in the game after stem cell therapy

Emerald IEditor’s Note: Deborah received human umbilical cord tissue-derived mesenchymal stem cells

My name is Deborah, from Southern California.

Occupation: Certified Interior Designer with a Masters degree in Interior Design.

Diagnosis: Patella chondromalacia with thinning of cartilage, mostly involving the medial facet and at the median. There is early degenerative changes with small marginal spurs involving the femoral patellar compartment and the medial and lateral femorotibial compartments. There is no fracture, osteochondral or loose body. Also localized inflammation of the Hoffa’s fat pad, anterior to the transverse. (All of these findings were from an MRI taken on June 15, 2011).

Symptoms before treatment: severe pain, difficulty in walking, bending, standing, sitting, exercising, sleeping…life was not fun.

Treatments/drugs: Aleve, Tylenol, Celebrex, acupuncture, physical therapy, custom brace, ace elastic braces, interviewed /consults with three independent orthopedic surgeons, possible knee replacement, arthroscopic surgery to mend torn meniscus.

My friend and ballroom dance competitor, Dr. Janet Vaughan convinced me after I had been researching other alternatives here in the United States for over a year, to contact Dr. Barnett at the Stem Cell Institute in Panama City, Panama to see if I was a candidate for stem cell therapy. Janet was kind enough to email Dr. Barnett for me and tell her I would be filling out the paperwork online and sending it to her ASAP. Dr. Barnett was extremely responsive and my husband and I soon had a conference call with Dr. Paz Rodriguez. He was kind, gracious and patient with all of our questions. We were soon on our way with an appointment to have stem cell therapy in Panama City, Panama!

I am now able to get back to my competitive ballroom dancing and doing well! I have less pain going up and down stairs (even though I am careful and always aware of my knees), I walk easier, exercise and am back to a normal life style. Am I at 100% ? No…but at 62 years old and being athletic all my life with snow skiing, water skiing, volleyball, tennis, racquetball, zoomba and other athletic movements I feel terrific even if I am at 80-90% of my capability! We are back to travelling the world and I am thrilled… I am living my life! And my knee is not dictating my life.

Impression of the clinic: The doctors, staff and driver, Javier were fabulous!!! Everyone made me and my husband feel comfortable and all were compassionate, personable, professional, helpful, friendly and always welcome to keep in touch! They always welcomed all of our questions and never made us feel uncomfortable in asking! Dr. Hernandez was with me all the way and gave me his cell number 24/7 and helped me through the language barrier since my Spanish is quiet weak! Everyone was just great!!!

What would I tell someone considering stem cell therapy: Do your homework… research and get referrals! You have nothing to lose and a life to gain! The Stem Cell Institute is terrific in their work and research! I have told many of my friends and individuals who find out through others that I had stem cell therapy. Unfortunately none have moved forward and try other options and still have no results…I feel sorry for them! Some do…and some do not.

Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014

The Stem Cell Institute, located in Panama City, Panama, will present an informational seminar about umbilical cord stem cell therapy on Saturday, September 20, 2014 in San Antonio, Texas at the La Cantera Hill Country Resort from 1:00 pm to 4:00 pm.

San Antonio, TX (PRWEB) September 11, 2014

The Stem Cell Institute, located in Panama City, Panama, will present an informational seminar about umbilical cord stem cell therapy on Saturday, September 20, 2014 in San Antonio, Texas at the La Cantera Hill Country Resort from 1:00 pm to 4:00 pm.
Stem Cell Institute Speakers include:

Neil Riordan PhD – “Umbilical Cord Stem Cell Clinical Trials for MS and Autism: Rationale and Clinical Protocols”
Dr. Riordan is the founder of the Stem Cell Institute and Medistem Panama Inc.

Jorge Paz-Rodriguez MD
– “Umbilical Cord Stem Cell Therapy for Arthritis, Inflammation and Sports Injuries”
Dr. Paz is the Medical Director at the Stem Cell Institute. He practiced internal medicine in the United States for over a decade before joining the Stem Cell Institute in Panama.

Special Guest Speaker:
Janet Vaughan, DDS, MS, Professional Dancer – “Successful Stem Cell Therapy in Panama: A Patient’s Perspective”
Dr. Vaughan is Board Certified in Orthodontics (Diplomate of the American Board of Orthodontics) and she is a Fellow in the International College of Dentistry.

She is a U.S. national Dance Sport Champion, currently holding national titles in 16 divisions of ballroom dancing including numerous gold medals. She was previously the #1 Pro/Am Ballroom Dancer in the United States.

Light snacks will be served afterwards. Our speakers and stem cell therapy patients will be on hand to share their personal experiences and answer questions.

Admission is free but space in limited and registration is required. For venue information and to register and reserve your tickets today, please visit: or call Cindy Cunningham, Patient Events Coordinator, at 1 (800) 980-7836.

About Stem Cell Institute Panama
Founded in 2007 on the principles of providing unbiased, scientifically sound treatment options; the Stem Cell Institute (SCI) has matured into the world’s leading adult stem cell therapy and research center. In close collaboration with universities and physicians world-wide, our comprehensive stem cell treatment protocols employ well-targeted combinations of autologous bone marrow stem cells, autologous adipose stem cells, and donor human umbilical cord stem cells to treat: autism, cerebral palsy, multiple sclerosis, spinal cord injury, osteoarthritis, rheumatoid arthritis, heart disease, and autoimmune diseases.

In partnership with Translational Biosciences, a subsidiary of Medistem Panama, SCI provides clinical services for ongoing clinical trials that are assessing safety and signs of efficacy for autism, multiple sclerosis, osteoarthritis, rheumatoid arthritis, and spinal cord injury using allogeneic umbilical cord tissue-derived mesenchymal stem cells (hUC-MSC), autologous stromal vascular fraction (SVF) and hU-MSC-derived mesenchymal trophic factors (MTF). In 2014, Translation Biosciences expects to expand its clinical trial portfolio to include heart disease and cerebral palsy.

For more information on stem cell therapy:

Stem Cell Institute Website:

Stem Cell Institute
Via Israel & Calle 66
Plaza Pacific Office #2A
Panama City, Panama

About Medistem Panama Inc.
Since opening its doors in 2007, Medistem Panama Inc. has developed adult stem cell-based products from human umbilical cord tissue and blood, adipose (fat) tissue and bone marrow. Medistem operates an 8000 sq. ft. ISO 9001-certified laboratory in the prestigious City of Knowledge. The laboratory is fully licensed by the Panamanian Ministry of Health and features 3 class 10000 clean rooms, class 100 laminar flow hoods, and class 100 incubators.

Medistem Panama Website:

Medistem Panama Inc.
Ciudad del Saber, Edif. 221 / Clayton
Panama, Rep. of Panama

Phone: +507 306-2601
Fax: +507 306-2601

About Translational Biosciences
A subsidiary of Medistem Panama Inc., Translational Biosciences was founded solely to conduct clinical trials using adult stem cells and adult stem cell-derived products.

Translational Biosciences Web Site:

After FDA Approval, Duchenne’s Muscular Dystrophy Patient Receives First Umbilical Cord Stem Cell Treatment in the United States

Ryan Benton, a 28 year-old Duchenne’s muscular dystrophy patient from Wichita, Kansas, received his first umbilical cord tissue-derived mesenchymal stem cell treatment yesterday at Asthma and Allergy Specialists of Wichita, KS following US FDA approval of his doctor’s application for a single patient, investigational new drug (IND) for compassionate use.

Wichita, KS (PRWEB) September 10, 2014

Picture of Ryan Benton

Ryan Benton

Ryan Benton, a 28 year-old Duchenne’s muscular dystrophy patient from Wichita, Kansas, received his first umbilical cord tissue-derived mesenchymal stem cell treatment yesterday following US FDA approval of his doctor’s application for a single patient, investigational new drug (IND) for compassionate use.

Duchenne muscular dystrophy (DMD) is a rapidly progressive form of muscular dystrophy that occurs primarily in boys. It is caused by an alteration (mutation) in a gene, called the DMD gene, which causes the muscles to stop producing the protein dystrophin. Individuals who have DMD experience progressive loss of muscle function and weakness, which begins in the lower limbs and leads to progressively worsening disability. Death usually occurs by age 25, typically from lung disorders. There is no known cure for DMD.

This trial, officially entitled “Allogeneic transplantation of human umbilical cord mesenchymal stem cells (UC-MSC) for a single male patient with Duchenne Muscular Dystrophy (DMD)” marks the first time the FDA has approved an investigational allogeneic stem cell treatment for Duchenne’s in the United States.

Ryan received his first intramuscular stem cell injections from allergy and immunology specialist, Van Strickland, M.D at Asthma and Allergy Specialists in Wichita, Kansas. He will receive 3 more treatments this week on consecutive days. Dr. Strickland will administer similar courses to Ryan every 6 months for a total of 3 years.

This is not the first time Ryan has undergone umbilical cord mesenchymal stem cell therapy. Since 2009, Ryan has been traveling to the Stem Cell Institute in Panama for similar treatments. Encouraging results from these treatments prompted Dr. Strickland to seek out a way to treat Ryan in the United States.

The stem cell technology being utilized in this trial was developed by renowned stem cell scientist Neil H. Riordan, PhD. Dr. Riordan is the founder and president of the Stem Cell Institute in Panama City, Panama and Medistem Panama. Medistem Panama is providing cell harvesting and banking services for their US-based cGMP laboratory partner.

Funding for this trial is being provided by the Aidan Foundation, a non-profit organization founded by Dr. Riordan in 2004 to provide financial assistance for alternative therapies to people like Ryan.

About Van Strickland, MD

Dr. Strickland came to Wichita in 1979 from his fellowship at the National Jewish Hospital in Denver. Since then he has spent one year in Wyoming, one year in Dallas, Texas and one year in Lee’s Summit Missouri before returning to full-time practice in Wichita, Kansas.

Dr. Strickland has been a clinical faculty member at The University of Kansas School of Medicine in Wichita in the department of Pediatrics and later in the department of internal medicine for most of his years in Wichita.

Dr. Strickland is certified by the American Board of Allergy and Immunology and the American Board of Pediatrics. He graduated from Baylor College of Medicine in Houston, Texas and served a full residency in Pediatrics at Baylor and a fellowship in Allergy and Immunology in Denver at National Jewish. He has trained in allergy and immunology at the University of Texas School of Medicine in Galveston as an elective while at Baylor and was a student on the team with Mary Ann South, MD and John Montgomery, MD who put baby David in the Bubble (Bubble Boy).

Dr. Strickland is a fellow of The American Academy of Allergy, Asthma and Immunology, The American College of Allergy, Asthma and Immunology, The American Association of Certified Allergists, The American Academy of Pediatrics, and The American College of Physicians. Dr Strickland has been recognized in the “Top Doctors in Wichita” listing several times.

Allergy & Asthma Consultants
MHV Strickland M.D.
10021 W. 21st St. Wichita, KS 67205

Phone: +1 (316) 722-4800
Toll-free: +1 (800) 347-4800
Fax: +1 (316) 722-5117

Web Site:

About Neil Riordan, PhD

Neil Riordan PhD is the co-founder of the Riordan-McKenna Institute, a regenerative orthopedics clinic that will open its doors in Southlake, Texas in late 2014. RMI will offer non-surgical stem cell treatments and stem cell enhanced surgeries for orthopedic conditions. He is the founder and chairman of Medistem Panama, Inc., (MPI) a leading stem cell laboratory and research facility located in the Technology Park at the prestigious City of Knowledge in Panama City, Panama. Founded in 2007, MPI stands at the forefront of applied research on adult stem cells for several chronic diseases. MPI’s stem cell laboratory is ISO 9001 certified and fully licensed by the Panamanian Ministry of Health. Dr. Riordan is the founder of Stem Cell Institute (SCI) in Panama City, Panama (est. 2007).

Under the umbrella of MPI subsidiary Translational Biosciences, MPI and SCI are currently conducting seven IRB-approved clinical trials in Panama for autism, multiple sclerosis, rheumatoid arthritis and osteoarthritis using human umbilical cord-derived mesenchymal stem cells, mesenchymal trophic factors and stromal vascular fraction. Additional trials for spinal cord injury, and cerebral palsy are scheduled to commence in late 2014 upon IRB approval.

Dr. Riordan’s research team collaborates with a number of universities and institutions, including National Institutes of Health, Indiana University, University of California, San Diego, University of Utah, University of Western Ontario, and University of Nebraska.

Dr. Riordan has published over 60 scientific articles in international peer-reviewed journals and authored two book chapters on the use of non-controversial stem cells from placenta and umbilical cord. He is listed on more the 25 patent families, including 11 issued patents including a 2010 patent for a new cellular cancer vaccine.

In 2007, Dr. Riordan’s research team was the first to discover and document the existence of mesenchymal-like stem cells in menstrual blood. For this discovery, his team was honored with the “Medical Article of the Year Award” from Biomed Central.
Neil Riordan, PhD

Riordan-McKenna Institute
801 E. Southlake Bivd.
Southlake, TX 76092

Phone: +1 (817) 776-8155
Fax: +1 (817) 776-8154


Stem Cell Therapy: Paralyzed Whitfield Co teen takes first steps, community pitching in

Posted: May 02, 2014 4:57 PM CDT Updated: May 02, 2014 6:05 PM CDT
By Kimberly Barbour, Reporter

Hannah LockeWHITFIELD COUNTY, GA (WRCB) – A North Georgia community is rallying around a teen girl recovering from a head-on car crash. She recently took her first steps since becoming paralyzed one year ago.

17-year-old Hannah Locke was riding in her family’s car last April when another car hit them head-on. She’s been confined to a wheelchair ever since, but now, a breakthrough.

Her community is trying to raise money for more treatment in hopes she’ll be able to walk on her own again someday.

Hannah is a junior at Coahulla Creek High School. Before the paralyzing accident she was a three sport athlete. Now her drive has shifted to getting out of the wheelchair she’s been in for the last year. She says it’s with her faith and community that she’s getting closer reaching that goal. Her friends are hoping to give her a boost this weekend.

It’s been a year full of challenges far beyond most teens, but Hannah Locke is only growing stronger.

She recently took her first steps since becoming paralyzed one year after a head-on crash. In just the last month, she’s re-gained some control over the lower half of her body.

“They laid me down and told me to try to kick my legs and they did it and we were all like, what just happened,” Hannah said.

Now she’s walking with a harness.

“Feeling emotion-wise, it’s exciting but feeling-wise, it’s weird to see my feet moving and not really be in complete control over them or feel them,” Hannah said.

“I don’t think we’ve ever been filled with so much joy before because I know how hard she works on a daily basis whether it’s therapy or here at home just getting out of bed, doing normal things me and you do that’s so much harder for her,” friend Jordan Greene said.

Hannah says people throughout Whitfield County have been there holding her hand through it all. They’ve held fundraisers to help pay some of her medical expenses, but this weekend they’re going bigger. They’ve organized a benefit concert featuring Christian musicians and some cast members from the show Duck Dynasty.

“People throughout the community were just like oh you need posters, we’ll print them, oh you need t-shirts we’ll do that, oh you need a gym, come use ours,” Greene said.

The money will pay for a return trip to Panama where Hannah hopes to get more stem cell injections that are helping re-connect the nerves in her legs.

Those who know her say they’ll do everything they can to get her back on her feet again. They say she’s a girl who inspires everyone she meets with her positive attitude and unwavering faith in God.

“He always finds a way to shine a light in the toughest storms,” Hannah said.

The concert is 5:30 p.m. Sunday at North Murray High School. Doors open at 4:45 p.m. They still half the seats available and will still be selling them at the door. General admission is $30 and floor preferred tickets are $60. For more info, call 800-965-9324 or email